GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV.
Quynh P NguyenDarcy WootenDaniel LeeManuel MorenoKatherine PromerAmutha RajagopalMatthew TanMichael TangKye DurenJeffrey YinLucas HillPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Use of GLP-1RAs led to declines in weight, BMI, and hemoglobin A1C among PWH and offers an additional strategy to address weight gain and diabetes.
Keyphrases
- weight gain
- weight loss
- glycemic control
- body mass index
- bariatric surgery
- birth weight
- antiretroviral therapy
- hiv positive
- roux en y gastric bypass
- hiv infected
- type diabetes
- gastric bypass
- hiv testing
- human immunodeficiency virus
- cardiovascular disease
- hepatitis c virus
- hiv aids
- men who have sex with men
- wild type
- obese patients
- red blood cell
- physical activity
- skeletal muscle